logo
N.J. firm made misleading websites in names of multiple Canadians and an alleged CRA scammer

N.J. firm made misleading websites in names of multiple Canadians and an alleged CRA scammer

CBC09-05-2025
If his Google Scholar profile is to be believed, Louis Arriola is a prolific scientist, having contributed to more than 700 scholarly articles about a wide range of unrelated disciplines from economics to advanced nanotechnology.
According to the profile, he contributed to a PhD dissertation on the automotive industry before he turned nine years old.
While the papers appear to be real, Arriola's contribution to the research is questionable. His name does not appear on the original publication in the 20 most recent entries on his profile and a university professor credited on more than 100 of the papers confirmed Arriola was not involved.
An investigation by CBC's The Fifth Estate has found that Arriola is among more than 100 people, including multiple Canadians, with a similar pattern of spam and false web content surrounding them. Website registration records, online advertising data and connections between fake social media profiles indicate that pattern points to a New Jersey reputation management firm called cleanyourname.com
David Rosenberg of Lakewood, N.J., who operates cleanyourname.com, advertises on his LinkedIn page that he can "delete online negative info fast," and that "by creating new and relevant content," his company is able to push negative online information "further down the search results in Google, Yahoo and Bing."
A LinkedIn post from Rosenberg states that only seven per cent of people go beyond the first page of search results.
"This meant that for reputation management, if we pushed down a negative to the third page," he wrote, "almost no one would see it."
In Arriola's case, looking beyond the first page of results and searching public records databases shows a long history of legal troubles.
An affidavit from an employee of the Canada Revenue Agency, submitted to Federal Court in 2020, says that Arriola was the operator of a "paper company" with "no real business activity" involved in a tax "scheme" that saw the agency pay out $63 million in what it called "illegitimate" refunds.
Arriola also was convicted in 2009 in California for a telecom-related fraud and has been named in civil lawsuits in multiple U.S. states that were pursuing him and companies he controlled for money that was loaned and allegedly never paid back.
His Google Scholar profile is one part of an interconnected cloud of misleading and spam websites. Blog posts about him link to an artist profile advertising stock images as his "work," as well as accounts at video sharing platforms and a website containing his name — louisarriola.net — which has connections to Rosenberg of cleanyourname.com.
The Fifth Estate has attempted to contact Arriola in multiple ways over the past two years but has received no response. For this story, contact was attempted via a LinkedIn profile that was recently active.
A good deal of the information about Arriola available online is true, making it difficult to separate fact from fiction. For instance, on his IMDB profile, he is listed as executive producer for the 2019 film Rambo: Last Blood, a fact supported by the appearance of his name in the end credits of the film.
"The whole point here is to confuse people, confuse people about the truth in relation to this particular person," said Ahmed Al-Rawi, director of The Disinformation Project at Simon Fraser University in Burnaby, B.C.
"As consumers of information, as readers, as users of the internet, the expectation is to factually understand the world around us," Al-Rawi said.
"If what we are ending up reading about is fake, we will have the wrong impression about what is around us, about the world, about the people we think we know."
IP address connections
Louisarriola.net was made available online by a server with a specific IP address, like a street address for the internet.
The Fifth Estate sent a message to a phone number associated with David Rosenberg of cleanyourname.com, asking if he was in control of the approximately 140 websites hosted at the same address as louisarriola.net.
Within a week, all but 19 of those 140 sites, including Arriola's, were scattered to a variety of new IP addresses. Many had been at that original IP address for multiple years.
Website registration records show that 14 of the 140 sites previously listed Rosenberg as registrant or administrator. Those records were made anonymous in 2018, around the same time that Rosenberg's name was removed from his own website — cleanyourname.com.
Many of the websites at the IP address followed a similar pattern, with the first and last name of the person the website was about in the URL.
A phone call to the number associated with Rosenberg was answered by a man who declined to identify himself.
"I think you have the wrong number," he said during the 25-second call and hung up.
A lawyer claiming to represent Rosenberg contacted The Fifth Estate, noting that he was in possession of questions sent via text message to that same phone number.
Since that phone call, neither the lawyer nor Rosenberg have responded to subsequent questions or correspondence.
On the internet, "you can make up things and create a facade, create a whole world in order to mislead people or create a certain type of reality," Al-Rawi said.
Artist profiles emerge online
In 2023, Dr. David Gerber, a gynecologist in midtown Toronto, was stated to have"engaged in disgraceful, dishonourable or unprofessional conduct with respect to 10 patients" by Ontario's physician regulator.
As the College of Physicians and Surgeons of Ontario was investigating patient complaints about Gerber and pursuing action against him, artist profiles in his name began appearing online. They claimed to show photographs, created by him, some even offering to sell the pictures at a specific price.
However, the works were not his, and appear to be part of a network of internet content created by Rosenberg. A number of the photos on Gerber's art profile also appear on a blog at drdavidgerbermd.com — a website that was hosted at the IP address linked to Rosenberg.
"After investigation, Dr. Gerber has learned that [a search engine optimization firm] in the U.S. who he retained from mid-2022 until August 2023, had without his knowledge, authorization or consent, created the sites," a lawyer for Gerber said in response to questions.
"Mr. Rosenberg was recommended to Dr. Gerber by a friend," the lawyer added in a subsequent email, stating that the physician "knew nothing of Mr. Rosenberg or any of his businesses prior to this referral."
While drdavidgerbermd.com was taken down following initial questions about it to Gerber, the site appears to have been reactivated when it was moved away from the Rosenberg-connected IP address.
"Mr. Rosenberg is no longer responding to Dr. Gerber's communications to him," Gerber's lawyer said.
"In respect of the websites and web pages and posts," he said, "they all constitute a form of impersonation, of which Dr. Gerber is the subject."
"Dr. Gerber is not," he added, responsible for "any website mill or the publication of disinformation" or "the use of spam or false and misleading content."
Other Canadians who had websites at that address include a Calgary orthodontist who admitted to taking payment for treatments and then not completing them and two finance professionals who ran into issues with the U.S. Securities and Exchange Commission.
A communications firm contacted The Fifth Estate regarding questions to those financiers, Marc Bistricer and Paul Zogala of Murchinson Ltd.
In regard to Rosenberg and cleanyourname.com, they said that "we have checked our vendor invoices during the time period you suggested and neither Murchinson nor the individuals in question ever hired this firm."
They declined to respond to further questions.
Bistricer, Zogala and Gerber each have profiles on the art sharing website Behance.com. Those profiles include "work" that is not their own and links to a variety of spam social media profiles. Behance users can post their own work, and follow the work of other artists they are interested in. Bistricer, Zogala and Gerber's work is followed by a nearly identical list of more than 50 accounts.
Their shared followers include five accounts that are variations on the name Mark Tompkins, as well as accounts for Jay Grieg, J. Grieg and Jason Allen Grieg.
Twelve of their shared followers are individuals who themselves had websites at the IP address The Fifth Estate asked Rosenberg about.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market
iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market

Globe and Mail

time30 minutes ago

  • Globe and Mail

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market

WOBURN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ('iSpecimen' or the 'Company'), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $1.75 million, before deducting fees to the placement agent and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering to pay $500,000 for marketing and advertising services to be provided by IR Agency LLC, and the remainder for working capital and general corporate purposes. In connection with the offering, the Company issued 1,559,828 shares of common stock (or pre-funded warrants to purchase shares of common stock) at a purchase price of $1.122 per share, priced at-the-market under Nasdaq rules. The offering closed on August 4, 2025. WestPark Capital, Inc. acted as the exclusive placement agent in connection with the offering. Additional details regarding the offering will be available in a Form 8-K to be filed by the Company with the Securities and Exchange Commission (the "SEC"). The securities described above have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement with the investor, the Company has agreed to file one or more registration statements with the SEC covering the resale of the shares of common stock and the shares issuable upon exercise of the pre-funded warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About iSpecimen iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit Safe Harbor Statement Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute 'forward-looking statements.' These statements include, but are not limited to, statements concerning the development of our company. The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The reader is cautioned not to rely on such forward-looking statements. Such forward-looking statements relate to future events or our future performance. In evaluating these forward-looking statements, you should consider various factors, including the uncertainty regarding future commercial success; risks and uncertainties associated with market conditions and the Company's ability to satisfy the closing conditions related to the Offering. These and other factors may cause our actual results to differ materially from any forward-looking statements. Forward-looking statements are only predictions and actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including factors discussed in the 'Risk Factors' section of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on April 14, 2025, as well as other SEC filings. Any forward-looking statements contained in this press release speak only as of the date hereof and, except as required by federal securities laws, iSpecimen specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Sylogist Ltd. Announces Details of Its Second Quarter 2025 Earnings Conference Call
Sylogist Ltd. Announces Details of Its Second Quarter 2025 Earnings Conference Call

Globe and Mail

timean hour ago

  • Globe and Mail

Sylogist Ltd. Announces Details of Its Second Quarter 2025 Earnings Conference Call

Calgary, Alberta--(Newsfile Corp. - August 4, 2025) - Sylogist Ltd. (TSX: SYZ) ("Sylogist" or the "Company"), a leading public sector SaaS company, is pleased to announce that its financial statements for the second quarter of fiscal year 2025 will be released before markets open on August 14th, 2025. The Company will host a conference call at 8:30 AM Eastern Time on August 14th, 2025. Bill Wood, Sylogist's President and Chief Executive Officer, and Sujeet Kini, Sylogist's Chief Financial Officer, will review the Company's financial results and business performance. Conference Call Details Date: Thursday, August 14, 2025 Time: 8:30 a.m. ET Participant Toll-Free Dial-In Number: 1-833-752-3805 [North America] 1-647-846-8841 [International] Webcast link: This conference call will be recorded and available for replay on the Company's website. About Sylogist Sylogist provides mission-critical SaaS solutions to over 2,000 public sector customers globally across the government, nonprofit, and education verticals. The Company's stock is traded on the Toronto Stock Exchange under the symbol SYZ. Information about Sylogist, inclusive of full financial statements together with Management's Discussion and Analysis, can be found at or at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store